|
|
||||||||||||||
|
|
|||||||||||||||
Department of Respiratory
Medicine, Freeman Hospital, High Heaton, Newcastle upon Tyne NE7 7DN,
UK
Correspondence to: Professor G J Gibson.
| The first 150 words of the full text of this article appear below. |
| |
Article |
|---|
The following three articles in this issue of
Thorax1-3 summarise the contributions to a
lively symposium on public health aspects of obstructive sleep apnoea
(OSA) which I had the pleasure of chairing at the meeting of the
British Thoracic Society in December 1997. The symposium followed the
publication in the BMJ of a systematic review by Wright
and colleagues on the health effects of obstructive sleep apnoea and
the effectiveness of continuous positive airway pressure.4
Their main conclusions were that the relevance of sleep apnoea to
public health had been exaggerated and the effectiveness of treatment
with continuous positive airway pressure (CPAP) had been poorly
evaluated. The authors questioned whether sleep apnoea was "a
separate disease entity or a marker or a symptom of obesity and
ageing" and they suggested that the morbidity associated with sleep
apnoea was due to confounding factors, particularly obesity. In
relation to CPAP treatment, they concluded
This article has been cited by other articles:
![]() |
H. Schafer, D. Pauleit, T. Sudhop, I. Gouni-Berthold, S. Ewig, and H. K. Berthold Body Fat Distribution, Serum Leptin, and Cardiovascular Risk Factors in Men With Obstructive Sleep Apnea* Chest, September 1, 2002; 122(3): 829 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Engleman When Does `Mild' Obstructive Sleep Apnea/Hypopnea Syndrome Merit Continuous Positive Airway Pressure Treatment? Am. J. Respir. Crit. Care Med., March 15, 2002; 165(6): 743 - 745. [Full Text] [PDF] |
||||
![]() |
R. Hubbard, J. Bennett, and S. Range British Thoracic Society Winter Meeting 1999 Thorax, May 1, 2000; 55(5): 432 - 433. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |